Daiwa Securities Group
PSTX

Daiwa Securities Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Daiwa Securities Group’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-346
Closed -$1K – 1406
2023
Q3 		$1K Hold
346
– – ﹤0.01% 1283
2023
Q2 		$1K Hold
346
– – ﹤0.01% 1309
2023
Q1 		$1K Hold
346
– – ﹤0.01% 1290
2022
Q4 		$2K Buy
346
+230
+198% +$1.05K ﹤0.01% 1246
2022
Q3 		$0 Hold
116
– – ﹤0.01% 1413
2022
Q2 		$0 Hold
116
– – ﹤0.01% 1445
2022
Q1 		$1K Hold
116
– – ﹤0.01% 1352
2021
Q4 		$1K Hold
116
– – ﹤0.01% 1367
2021
Q3 		$1K Hold
116
– – ﹤0.01% 1291
2021
Q2 		$1K Hold
116
– – ﹤0.01% 1227
2021
Q1 		$1K Hold
116
– – ﹤0.01% 1238
2020
Q4 		$1K Buy
+116
New +$1.22K ﹤0.01% 1219

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Daiwa Securities Group's PSTX Position: Q4 2023 in Review

Daiwa Securities Group sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q4 2023, closing a stake of 346 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in PSTX in Q4 2020 and held it in 12 quarters. The position peaked at $2K in Q4 2022. 91 funds tracked by Wall St. Rank hold PSTX as of Q4 2023.

  • Daiwa Securities Group reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 346 Poseida Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $1K.
  • Daiwa Securities Group first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2020 and held it in 12 quarters.
  • Daiwa Securities Group's Poseida Therapeutics, Inc. Common Stock position peaked at $2K in Q4 2022.
  • 91 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.